Pediatric transplantation · 2026
Fulminant Synchronous Epstein-Barr Virus-Positive MALT Lymphoma and Diffuse Large B-Cell Lymphoma Monomorphic Post-Transplant Lymphoproliferative Disorder in a Child Following Heart Transplant: A Case Report.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Elias Anna J, Larson Daniel P, Ameduri Rebecca K, Galardy Paul J
Аннотация
BACKGROUND: Post-transplant lymphoproliferative disorder (PTLD) is a devastating complication following solid-organ and hematopoietic stem cell transplantation. While PTLD is often effectively managed with immunotherapy or immuno-chemotherapy, rare cases present in a fulminant manner and are rapidly life-threatening.
METHODS: We describe a case of an Epstein-Barr virus (EBV)-negative 16-year-old who developed EBV DNAemia and rapidly fulminant monomorphic PTLD within five months of receiving a heart transplant from an EBV-positive donor.
RESULTS/IMPORTANT CLINICAL FINDINGS: Three months after transplant the patient developed EBV DNAemia, cytopenias, and severe gastrointestinal symptoms that led to the diagnosis of monomorphic PTLD, EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). The patient underwent immunotherapy, followed by two different immuno-chemotherapy regimens, none of which slowed the rapid progression of the disease. One month after the initial diagnosis, a repeat biopsy revealed the emergence of a distinct monomorphic PTLD, EBV-positive diffuse large B-cell lymphoma (DLBCL). The patient died of disease 10 weeks after diagnosis.
CONCLUSIONS: The case exemplifies a fulminant case of EBV-positive MALT lymphoma as a form of monomorphic PTLD in a child. The case illustrates that MALT lymphoma may have an aggressive natural history, and the apparent rapid emergence of a distinct form of PTLD reinforces the need for repeat tissue sampling upon disease relapse or when the clinical behavior does not match the expectation.
METHODS: We describe a case of an Epstein-Barr virus (EBV)-negative 16-year-old who developed EBV DNAemia and rapidly fulminant monomorphic PTLD within five months of receiving a heart transplant from an EBV-positive donor.
RESULTS/IMPORTANT CLINICAL FINDINGS: Three months after transplant the patient developed EBV DNAemia, cytopenias, and severe gastrointestinal symptoms that led to the diagnosis of monomorphic PTLD, EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). The patient underwent immunotherapy, followed by two different immuno-chemotherapy regimens, none of which slowed the rapid progression of the disease. One month after the initial diagnosis, a repeat biopsy revealed the emergence of a distinct monomorphic PTLD, EBV-positive diffuse large B-cell lymphoma (DLBCL). The patient died of disease 10 weeks after diagnosis.
CONCLUSIONS: The case exemplifies a fulminant case of EBV-positive MALT lymphoma as a form of monomorphic PTLD in a child. The case illustrates that MALT lymphoma may have an aggressive natural history, and the apparent rapid emergence of a distinct form of PTLD reinforces the need for repeat tissue sampling upon disease relapse or when the clinical behavior does not match the expectation.